JOINT FILING AND SOLICITATION AGREEMENTJoint Filing and Solicitation Agreement • August 5th, 2020 • Couchman Jonathan • Biological products, (no disgnostic substances) • New York
WHEREAS, certain of the undersigned are stockholders, direct or beneficial, of Enzon Pharmaceuticals, Inc., a Delaware corporation (the “Company”);
Joint Filing AgreementJoint Filing Agreement • March 27th, 2020 • Couchman Jonathan • Biological products, (no disgnostic substances)
The undersigned hereby agree that the Statement on Schedule 13G dated March 27, 2020 with respect to the shares of Common Stock of Enzon Pharmaceuticals, Inc., and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
JOINT FILING AGREEMENTJoint Filing Agreement • April 16th, 2020 • Couchman Jonathan • Biological products, (no disgnostic substances)
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the Common Stock, par value $0.01 per share, of Enzon Pharmaceuticals, Inc., a Delaware corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Joint Filing AgreementJoint Filing Agreement • April 13th, 2018 • Couchman Jonathan • Biological products, (no disgnostic substances)
The undersigned hereby agree that the Statement on Schedule 13G dated April 12, 2018 with respect to the shares of Common Stock of Enzon Pharmaceuticals, Inc., and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
JOINT FILING AGREEMENTJoint Filing Agreement • August 22nd, 2014 • Couchman Jonathan • Pharmaceutical preparations
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Common Stock, $0.001 par value, of Affymax, Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
JOINT FILING AGREEMENTJoint Filing Agreement • September 17th, 2020 • Couchman Jonathan • Biological products, (no disgnostic substances)
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the Common Stock, par value $0.01 per share, of Enzon Pharmaceuticals, Inc., a Delaware corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
